UB Paderborn / Katalog / Suche / in CDI

Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients

Journal of hepatology, 2019-08, Vol.71 (2), p.265-273

2019

Volltextzugriff (PDF)

Immune landscape and in vivo immunogenicity of NY-ESO-1 tumor antigen in advanced neuroblastoma patients

BMC cancer, 2018-10, Vol.18 (1), p.983-983, Article 983

2018

Volltextzugriff (PDF)

1 Dissecting β-catenin associated inflammation in patients with desmoid fibromatosis to identify prognostic biomarkers

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A1-A1

2021

Volltextzugriff (PDF)

Melanoma Stem Cell Sphere Formation Assay

Bio-protocol, 2017-04, Vol.7 (8), p.e2233-e2233

2017

Volltextzugriff (PDF)

Heat shock proteins: biological functions and clinical application as personalized vaccines for human cancer

Cancer Immunology, Immunotherapy, 2004-03, Vol.53 (3), p.227-233

2004

Volltextzugriff (PDF)

LAG-3 expression defines a subset of CD4(+)CD25(high)Foxp3(+) regulatory T cells that are expanded at tumor sites

The Journal of immunology (1950), 2010-06, Vol.184 (11), p.6545-6551

2010

Volltextzugriff (PDF)

Hepatitis C virus eradication by direct-acting antiviral agents improves carotid atherosclerosis in patients with severe liver fibrosis

Journal of hepatology, 2018-07, Vol.69 (1), p.18-24

2018

Volltextzugriff (PDF)

Reduced incidence of type 2 diabetes in patients with chronic hepatitis C virus infection cleared by direct‐acting antiviral therapy: A prospective study

Diabetes, obesity & metabolism, 2020-12, Vol.22 (12), p.2408-2416

2020

Volltextzugriff (PDF)

Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon

Alimentary pharmacology & therapeutics, 2017-01, Vol.45 (1), p.160-168

2017

Volltextzugriff (PDF)

Hepatobiliary phase in cirrhotic patients with different Model for End-stage Liver Disease score: comparison of the performance of gadoxetic acid to gadobenate dimeglumine

European radiology, 2019-06, Vol.29 (6), p.3090-3099

2019

Volltextzugriff (PDF)

Point‐of‐care HCV RNA testing in the setting of DAA therapy: HCV‐FiS (HEpatitis C Virus Fingerstick Study)

Liver international, 2019-12, Vol.39 (12), p.2240-2243

2019

Volltextzugriff (PDF)

Hepatitis C virus eradication by direct antiviral agents abates oxidative stress in patients with advanced liver fibrosis

Liver international, 2020-11, Vol.40 (11), p.2820-2827

2020

Volltextzugriff (PDF)

Immunomodulatory Factors Control the Fate of Melanoma Tumor Initiating Cells

Stem cells (Dayton, Ohio), 2016-10, Vol.34 (10), p.2449-2460

2016

Volltextzugriff (PDF)

SAT-223-AA genotype of the deSNP rs6726639 of gene MERTK (MER Tyrosine Kinase) is associated with development of hepatocellular carcinoma after hepatitis C virus clearance

Journal of hepatology, 2019-04, Vol.70 (1), p.e728-e728

2019

Volltextzugriff (PDF)

Aminopyrine breath test predicts liver‐related events and death in HCV‐related cirrhosis on SVR after DAA therapy

Liver international, 2020-03, Vol.40 (3), p.530-538

2020

Volltextzugriff (PDF)

Biological quality control for extracorporeal photochemotherapy: Assessing mononuclear cell apoptosis levels in ECP bags of chronic GvHD patients

Journal of clinical apheresis, 2015-06, Vol.30 (3), p.162-170

2015

Volltextzugriff (PDF)

Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: a case report

BMC cancer, 2015-02, Vol.15 (1), p.58-58, Article 58

2015

Volltextzugriff (PDF)

Soluble human LAG-3 molecule amplifies the In vitro generation of type 1 tumor-specific immunity

Cancer research (Chicago, Ill.), 2006-04, Vol.66 (8), p.4450-4460

2006

Volltextzugriff (PDF)

Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cells

Cancer research (Chicago, Ill.), 2001, Vol.61 (1), p.222-227

2001

Volltextzugriff (PDF)

The apoptosis inhibitor protein survivin induces tumor-specific CD8+ and CD4+ T cells in colorectal cancer patients

Cancer research (Chicago, Ill.), 2003-08, Vol.63 (15), p.4507-4515

2003

Volltextzugriff (PDF)

LAG-3 expression and role in human pDC biology

Frontiers in immunology, 2013, Vol.4

2013

Volltextzugriff (PDF)

LAG-3 Expression Defines a Subset of CD4+CD25highFoxp3+ Regulatory T Cells That Are Expanded at Tumor Sites

The Journal of immunology (1950), 2010-06, Vol.184 (11), p.6545-6551

2010

Volltextzugriff (PDF)

Identification of a mutated receptor-like protein tyrosine phosphatase kappa as a novel, class II HLA-restricted melanoma antigen

The Journal of immunology (1950), 2003-06, Vol.170 (12), p.6363-6370

2003

Volltextzugriff (PDF)

A superagonist variant of peptide MART1/melan A27-35 elicits anti-melanoma CD8+ T cells with enhanced functional characteristics : Implication for more effective immunotherapy

Cancer research (Chicago, Ill.), 1999-01, Vol.59 (2), p.301-306

1999

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients

Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre study

Immune landscape and in vivo immunogenicity of NY-ESO-1 tumor antigen in advanced neuroblastoma patients

1 Dissecting β-catenin associated inflammation in patients with desmoid fibromatosis to identify prognostic biomarkers

Melanoma Stem Cell Sphere Formation Assay

Heat shock proteins: biological functions and clinical application as personalized vaccines for human cancer

LAG-3 expression defines a subset of CD4(+)CD25(high)Foxp3(+) regulatory T cells that are expanded at tumor sites

Hepatitis C virus eradication by direct-acting antiviral agents improves carotid atherosclerosis in patients with severe liver fibrosis

Reduced incidence of type 2 diabetes in patients with chronic hepatitis C virus infection cleared by direct‐acting antiviral therapy: A prospective study

Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon

Hepatobiliary phase in cirrhotic patients with different Model for End-stage Liver Disease score: comparison of the performance of gadoxetic acid to gadobenate dimeglumine

Point‐of‐care HCV RNA testing in the setting of DAA therapy: HCV‐FiS (HEpatitis C Virus Fingerstick Study)

Hepatitis C virus eradication by direct antiviral agents abates oxidative stress in patients with advanced liver fibrosis

Immunomodulatory Factors Control the Fate of Melanoma Tumor Initiating Cells

SAT-223-AA genotype of the deSNP rs6726639 of gene MERTK (MER Tyrosine Kinase) is associated with development of hepatocellular carcinoma after hepatitis C virus clearance

Aminopyrine breath test predicts liver‐related events and death in HCV‐related cirrhosis on SVR after DAA therapy

Biological quality control for extracorporeal photochemotherapy: Assessing mononuclear cell apoptosis levels in ECP bags of chronic GvHD patients

Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: a case report

Soluble human LAG-3 molecule amplifies the In vitro generation of type 1 tumor-specific immunity

Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cells

The apoptosis inhibitor protein survivin induces tumor-specific CD8+ and CD4+ T cells in colorectal cancer patients

LAG-3 expression and role in human pDC biology

LAG-3 Expression Defines a Subset of CD4+CD25highFoxp3+ Regulatory T Cells That Are Expanded at Tumor Sites

Identification of a mutated receptor-like protein tyrosine phosphatase kappa as a novel, class II HLA-restricted melanoma antigen

A superagonist variant of peptide MART1/melan A27-35 elicits anti-melanoma CD8+ T cells with enhanced functional characteristics : Implication for more effective immunotherapy

Suchergebnisse filtern